Charles Schwab
OTIC

Charles Schwab’s Otonomy, Inc. OTIC Stock Holding History

Charles Schwab’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,843
Closed -$36K – 3571
2022
Q2 		$36K Hold
16,843
– – ﹤0.01% 3442
2022
Q1 		$41K Hold
16,843
– – ﹤0.01% 3553
2021
Q4 		$36K Hold
16,843
– – ﹤0.01% 3537
2021
Q3 		$33K Hold
16,843
– – ﹤0.01% 3484
2021
Q2 		$38K Hold
16,843
– – ﹤0.01% 3398
2021
Q1 		$43K Hold
16,843
– – ﹤0.01% 3454
2020
Q4 		$109K Sell
16,843
-15,000
-47% -$68.1K ﹤0.01% 3316
2020
Q3 		$129K Buy
+31,843
New +$120K ﹤0.01% 3236
2019
Q3 		– Sell
-17,686
Closed -$49K – 3202
2019
Q2 		$49K Hold
17,686
– – ﹤0.01% 3150
2019
Q1 		$47K Buy
+17,686
New +$39.8K ﹤0.01% 3143
2018
Q3 		– Sell
-81,750
Closed -$315K – 3145
2018
Q2 		$315K Sell
81,750
-32,866
-29% -$137K ﹤0.01% 2943
2018
Q1 		$482K Buy
114,616
+3,744
+3% +$20.4K ﹤0.01% 2739
2017
Q4 		$616K Buy
+110,872
New +$481K ﹤0.01% 2672
2017
Q3 		– Sell
-129,642
Closed -$2.44M – 3099
2017
Q2 		$2.44M Buy
129,642
+14,856
+13% +$207K ﹤0.01% 2155
2017
Q1 		$1.41M Buy
114,786
+6,798
+6% +$99K ﹤0.01% 2319
2016
Q4 		$1.72M Buy
107,988
+6,363
+6% +$107K ﹤0.01% 2237
2016
Q3 		$1.85M Buy
101,625
+63,186
+164% +$1.03M ﹤0.01% 2169
2016
Q2 		$611K Buy
38,439
+8,300
+28% +$124K ﹤0.01% 2523
2016
Q1 		$450K Buy
30,139
+9,100
+43% +$143K ﹤0.01% 2618
2015
Q4 		$584K Hold
21,039
– – ﹤0.01% 2582
2015
Q3 		$375K Hold
21,039
– – ﹤0.01% 2736
2015
Q2 		$484K Buy
21,039
+10,539
+100% +$296K ﹤0.01% 2682
2015
Q1 		$372K Hold
10,500
– – ﹤0.01% 2747
2014
Q4 		$350K Buy
+10,500
New +$281K ﹤0.01% 2785

Other funds holding OTIC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Charles Schwab's OTIC Position: Q3 2022 in Review

Charles Schwab sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 16,843 shares — an estimated $36K sold.

Charles Schwab first reported a position in OTIC in Q4 2014 and held it in 24 quarters. The position peaked at $2.44M in Q2 2017. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

  • Charles Schwab reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
  • Charles Schwab sold 16,843 Otonomy, Inc. shares in Q3 2022, an estimated $36K.
  • Charles Schwab first reported a position in Otonomy, Inc. in Q4 2014 and held it in 24 quarters.
  • Charles Schwab's Otonomy, Inc. position peaked at $2.44M in Q2 2017.
  • 40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.